Open Label Placebo in the Treatment of Low Back Pain
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Patients will be randomized to receive open-label (honestly described placebo) immediately at
baseline or be eligible to receive the open-label treatment three weeks after the baseline
measurements. Therefore all patients will be eligible to receive open-label placebo treatment
for their chronic low back pain during the course of the study.